-- 加拿大皇家银行资本市场（RBC Capital Markets）周三发布的研究报告指出，鉴于摩根士丹利（MS）第一季度业绩强劲，其资本充裕，很可能通过股票回购和提高股息来回报股东。 RBC分析师表示，摩根士丹利拥有多元化增长引擎的投资服务业务模式，在第一季度取得了“卓越”的业绩，这主要得益于其一流的投资银行和交易业务。 报告指出，第一季度有形普通股股东权益回报率较上年同期增长至27.1%，这验证了其将机构证券、财富管理和投资管理整合为一个“统一飞轮”式盈利引擎的战略。 该券商目前预计摩根士丹利2026年和2027年的每股收益分别为12.10美元和12.80美元，高于此前预测的12美元和12.60美元。 RBC重申了对该股的“与行业持平”评级和每股207美元的目标价。
Price: $188.62, Change: $-3.00, Percent Change: -1.57%
Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.
Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.
Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.